| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/04/2006 | EP1294725B1 Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 01/04/2006 | EP1242403B1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 01/04/2006 | EP1237553B1 The combination of a serotonin reuptake inhibitor and a 5-ht 2c? antagonist, inverse agonist or partial agonist |
| 01/04/2006 | EP1223950B1 Ribozyme therapy for the treatment of proliferative eye diseases |
| 01/04/2006 | EP1173172B1 Synergistic effects of amlodipine and the hydroxylated metabolite of atorvastatin |
| 01/04/2006 | EP1083898B1 Novel use of hiv protease inhibiting compounds |
| 01/04/2006 | EP1067945B1 Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions |
| 01/04/2006 | CN1717401A Anilinopyrazole derivatives useful for the treatment of diabetes |
| 01/04/2006 | CN1717391A Inhibitors of glycogen synthase kinase 3 |
| 01/04/2006 | CN1717389A Phenyl substituted piperidine compounds for use as PPAR activators |
| 01/04/2006 | CN1717268A Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone |
| 01/04/2006 | CN1717253A Solid preparation |
| 01/04/2006 | CN1715280A Aryl fused azapolycyclic compounds |
| 01/04/2006 | CN1715269A Cyanopyrrolidine derivatives |
| 01/04/2006 | CN1714869A Anhydrous topical skin preparations |
| 01/04/2006 | CN1714866A A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes |
| 01/04/2006 | CN1714832A Medicinal composition with synergetic function |
| 01/04/2006 | CN1714815A Bee glue and saussurea involucrata wine |
| 01/04/2006 | CN1714807A Plant extract with blood sugar lowering activity and its use |
| 01/04/2006 | CN1714806A Aipushengting sauce and its preparing method |
| 01/04/2006 | CN1714800A Nano calcium powder of live stock and fowl bones and its preparing method |
| 01/04/2006 | CN1714786A Medicinal composition of silibin |
| 01/04/2006 | CN1234694C New imidazoline compound, its preparation method and drug composition containing them |
| 01/04/2006 | CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 01/04/2006 | CN1234688C 3-arylindole and their use as cb2 receptor agonists |
| 01/04/2006 | CN1234417C Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same |
| 01/04/2006 | CN1234414C Drugs for complications of diabetes and neuropathy and utilization thereof |
| 01/04/2006 | CN1234386C Diabetes treating medicine and its preparation |
| 01/04/2006 | CN1234379C Capsule for reducing hyperlipemia |
| 01/04/2006 | CN1234357C Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/04/2006 | CN1234343C Fat lowered bathing powder and preparing method |
| 01/04/2006 | CN1234299C Nutrient flour special for diabetes and hypertension patients |
| 01/03/2006 | US6982362 for diagnosis/treatment of arteriosclerosis, diabetes; stem cells |
| 01/03/2006 | US6982353 C2-disubstituted indan-1-ol compounds, their derivatives, processes for their preparation, and their use as pharmaceuticals |
| 01/03/2006 | US6982286 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO), treat an inflammatory disease or condition, a disease related to carbohydrate metabolism, smooth muscle cell function |
| 01/03/2006 | US6982278 For modulating a peroxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982270 1-Phenyl-2-oxo-3,4-dihydro-6-phenylaminoquinazoline for example; cytokine suppressive anti-inflammatory drugs; combination therapy |
| 01/03/2006 | US6982267 For therapy of metabolic and eating disorders such as obesity and hyperphagia, and therapy of diabetes |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | US6982259 N-heterocyclic derivatives as NOS inhibitors |
| 01/03/2006 | US6982258 Low-calcemic oxime analogs of 1α,25-dihydroxy vitamin D3 |
| 01/03/2006 | US6982157 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s) -3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3A4 |
| 01/03/2006 | CA2359476C Hypolipidemic and antioxidant morpholine derivatives |
| 01/03/2006 | CA2345818C Process for the preparation of oral pharmaceutical compositions comprising biphosphonates |
| 01/03/2006 | CA2329005C Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 01/03/2006 | CA2253635C Use of aspirochlorine or derivatives thereof as immunosuppressive agents |
| 01/03/2006 | CA2176117C Generation of high titers of recombinant aav vectors |
| 01/03/2006 | CA2138974C Dermatological agent for aiding oxygen transport in the skin |
| 12/29/2005 | WO2005123735A1 Process for producing evodiamine-containing composition |
| 12/29/2005 | WO2005123725A1 Novel compound having lipase inhibitory activity |
| 12/29/2005 | WO2005123718A2 Benzimidazolone carboxylic acid derivatives |
| 12/29/2005 | WO2005123668A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 12/29/2005 | WO2005123082A1 An anti-hyperlipemia composition |
| 12/29/2005 | WO2005123056A1 Use of alpha-ketoglutarate and related compounds for lowering plasma lipids |
| 12/29/2005 | WO2004034965A3 Method for treating cancer |
| 12/29/2005 | WO2003033671A3 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/29/2005 | WO2003012122A3 Crystallized structure of type iv collagen nc1 domain hexamer |
| 12/29/2005 | US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 12/29/2005 | US20050289658 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 12/29/2005 | US20050288513 Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use |
| 12/29/2005 | US20050288501 Reducing a 2-(protected amino)-3-(piperazin-1-yl, N-morpholinyl, or N-thiomorpholinyl) propanoate, deprotecting the amine, and reacting with t-butylisothiocyanate |
| 12/29/2005 | US20050288487 Human mast cell-expressed membrane proteins |
| 12/29/2005 | US20050288370 Polymorphic forms are suitable for use as active substances of pharmaceutical dosage forms for reduction of serum cholesterol levels in the bloodstream |
| 12/29/2005 | US20050288368 Compositions and methods for treating and preventing necrosis |
| 12/29/2005 | US20050288360 Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone |
| 12/29/2005 | US20050288355 Combination therapy wherein a serotonin reuptake inhibitor is used |
| 12/29/2005 | US20050288353 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 12/29/2005 | US20050288340 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 12/29/2005 | US20050288339 Medicinal compositions containing diuretic and insulin resistance-improving agent |
| 12/29/2005 | US20050288337 Novel compounds |
| 12/29/2005 | US20050288335 Triamide-substituted heterobicyclic compounds |
| 12/29/2005 | US20050288325 Therapy for andropause using estrogen agonists/antagonists and testosterone |
| 12/29/2005 | US20050288321 Alzheimer's disease ; 3-(2,3-dihydro-5,6-difluorobenzofur-7-yl)-4-[1-(piperidin-4-yl)-1H-indol-3-yl]pyrrole-2,5-dione; stimulating bone deposition |
| 12/29/2005 | US20050288313 Synergistically combined with immunomodulators or antiinflammtory agents; treating rheumatoid arthritis; inhibiting organ transplant rejection; Janus Kinase 3 inhibitors such as CP 690550, 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile |
| 12/29/2005 | US20050288311 2-(dipropylamino)-8-(4-thiomorpholinyl)pyrido[3,4-d]pyrimidin-4(3H)-one; kianses inhibitor; anticarcinlgenic, antidiabetic, antiinflammatory, hypotensive agent; nontoxic |
| 12/29/2005 | US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 12/29/2005 | US20050288285 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 12/29/2005 | US20050288275 New compounds |
| 12/29/2005 | US20050288254 Treating sepsis or septic shock by administering 1-stearoyl, 1-palmitoyl-, 1-myristoyl- lysophosphatidylcholine, or 1-oleoyllysophosphatidylcholine or sphingosylphosphorylcholine. |
| 12/29/2005 | US20050288248 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 12/29/2005 | US20050288219 Osteoprotegerin in milk |
| 12/29/2005 | US20050288213 Combination therapy for the treatment of obesity |
| 12/29/2005 | US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 12/29/2005 | US20050287546 Novel proteases |
| 12/29/2005 | US20050287233 Compositions for preventing or ameliorating multiple risk factor syndromes |
| 12/29/2005 | US20050287207 Solid preparation |
| 12/29/2005 | CA2569459A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 12/29/2005 | CA2568902A1 Use of alpha-ketoglutarate and related compounds for lowering plasma lipids |
| 12/29/2005 | CA2568539A1 Small molecules for treatment of hypercholesterolemia and related diseases |
| 12/29/2005 | CA2568394A1 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 12/28/2005 | EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/28/2005 | EP1609858A1 Branched neutral amino acid transporters acting as single molecule |
| 12/28/2005 | EP1609852A1 Bifidobacteria and preparations containing them |
| 12/28/2005 | EP1609803A1 Modified antibody against cd22 and utilization thereof |
| 12/28/2005 | EP1609799A1 Heteroaryl 5-thio-beta-d-glucopyranoside derivatives and remedies for diabetes containing the same |
| 12/28/2005 | EP1609798A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 12/28/2005 | EP1609797A1 Compound having affinity with calcified tissue |
| 12/28/2005 | EP1609791A1 Preparation of [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-Chloro-2-thienyl)methy]propy]amino]-3H-imidazo[4,5-b]pyridin-3-y]-N-ethyl-2,3-dihydroxycyclopentanecarboxamide |
| 12/28/2005 | EP1609785A1 C-glycoside derivatives and salts thereof |